Publication Name	World Journal of Virology
Manuscript ID	63465
Country	Thailand

Received	2021-01-28 14:59
Peer-Review Started	2021-01-28 15:05
To Make the First Decision
Return for Revision	2021-02-25 01:25
Revised	2021-03-10 14:27
Second Decision	2021-04-26 08:51
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-04-26 11:37
Articles in Press	2021-04-26 11:37
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-05-14 19:47
Typeset the Manuscript	2021-05-18 01:47
Publish the Manuscript Online	2021-05-18 11:27

ISSN	2220-3249 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medicine, General & Internal
Manuscript Type	Minireviews
Article Title	Angiotensin-converting enzyme 2 receptors, chronic liver diseases, common medications, and clinical outcomes in COVID-19 patients
Manuscript Source	Invited Manuscript
All Author List	Wattana Leowattana
Funding Agency and Grant Number
Corresponding Author	Wattana Leowattana, BSc, MD, MSc, PhD, Associate Professor, Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, 420/6 rajavithi road, rachatawee, Bangkok 10400, Thailand. wattana.leo@mahidol.ac.th
Key Words	SARS-CoV-2; COVID-19; Hepatobiliary tissue; Angiotensin converting enzyme 2; Chronic liver disease; Common medications; Clinical outcome
Core Tip	With more than 100 million confirmed cases worldwide, hepatobiliary injury has been reported in many coronavirus disease 2019 (COVID-19) patients. The association between COVID-19 and hepatobiliary injury refers to any hepatobiliary damage during disease progression and treatment in COVID-19 patients with or without chronic liver diseases or common medications. Angiotensin-converting enzyme 2 receptor may be a significant factor in hepatobiliary derangement due to its highly expressed cholangiocyte, and it is also an entry point of severe acute respiratory syndrome coronaviruses 2. Moreover, drug-induced liver injury and cytokine storm may be an added risk in severe clinical outcomes. Close monitoring of the liver function in COVID-19 patients is mandatory.
Publish Date	2021-05-18 11:27
Citation	Leowattana W. Angiotensin-converting enzyme 2 receptors, chronic liver diseases, common medications, and clinical outcomes in COVID-19 patients. World J Virol 2021; 10(3): 86-96
URL	https://www.wjgnet.com/2220-3249/full/v10/i3/86.htm
DOI	https://dx.doi.org/10.5501/wjv.v10.i3.86

Full Article (PDF)	WJV-10-86.pdf
Full Article (Word)	WJV-10-86.docx
Manuscript File	63465-Review-FilipodiaCL.docx
Answering Reviewers	63465-Answering reviewers.pdf
Audio Core Tip	63465-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	63465-Conflict-of-interest statement.pdf
Copyright License Agreement	63465-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	63465-Language certificate.pdf
Peer-review Report	63465-Peer-review(s).pdf
Scientific Misconduct Check	63465-Bing-Wang JL-1.jpg
Scientific Misconduct Check	63465-Scientific misconduct check.pdf
Scientific Editor Work List	63465-Scientific editor work list.pdf